Biocept Inc.

NASDAQ: BIOCHealthcare / Medical Laboratories & Research / USA
1.06+0.0300+2.91%Vol 2 241 8601Y Perf -83.12%
Jul 22nd, 2019 16:00
BID1.03 ASK1.05
Open1.05 Previous Close1.03
Pre-Market1.07 After-Trading1.06
 0.04 3.88%  - -%
Target Price
4.42 
Analyst Rating
Strong Buy 1.00
Potencial %
316.98 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★★     53.02
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)20 
Earnings Rating
Buy
Price Range Ratio 52wk %
6.59 
Earnings Date
13th Aug 2019

Today's Price Range

1.031.15

52wk Range

0.66006.73

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
0.00%
1 Month
-0.93%
3 Months
11.58%
6 Months
-44.79%
1 Year
-83.12%
3 Years
-98.10%
5 Years
-99.79%
10 Years
-

Name / TickerPriceChg.Chg.%
BIOC1.060.03002.91
AAPL207.224.63002.29
GOOG1 138.077.97000.71
MSFT138.431.81001.32
XOM75.070.08000.11
WFC46.480.45000.98
JNJ128.64-1.6700-1.28
FB202.323.96002.00
GE10.210.17001.69
JPM114.270.73000.64
Earnings HistoryEstimateReportedSurprise %
Q01 2019--0.61-
Q04 2018-1.50-1.434.67
Q03 2018-1.71-2.42-41.52
Q02 2018-3.30-2.7018.18
Q01 2018-2.10-3.30-57.14
Q04 2017-5.71-5.415.25
Q03 2017-5.71-6.01-5.25
Q02 2017-6.01-6.31-4.99
Earnings Per EndEstimateRevision %Trend
12/2018 QR-1.50-22.95Negative
12/2018 QR-1.2218.67Positive
12/2019 FY-3.1617.71Positive
12/2019 FY-3.8410.28Positive
Next Report Date13th Aug 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume2 241 860
Shares Outstanding (in ths.)18 867
Trades Count2 560
Dollar Volume2 174 286
Avg. Volume3 238 323
Avg. Weekly Volume698 148
Avg. Monthly Volume569 627
Avg. Quarterly Volume3 733 080
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
3 (75.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
1 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.50

Biocept Inc.

Biocept Inc is an early commercial-stage molecular oncology diagnostics company. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA assays utilizing a standard blood sample. The company's lung, breast, and gastric cancer assays provide information to oncologists and other physicians that enable them to select personalized treatment for their patients based on detailed data on the characteristics of tumors. Its products include CEE-Sure BCT, and Target Selector Kits. Geographically, it operates through the United States, which is also the revenue generation region for the group.

CEO: Michael W. Nall

Teplephone: +1 858 320-8200

Address: 5810 Nancy Ridge Drive, San Diego 92121, CA, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

43%57%

Bearish Bullish

60%40%

Bearish Bullish

55%45%

News